Skip to main content

Peer Review reports

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

Original Submission
4 Oct 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
11 May 2015 Editorially accepted
20 May 2015 Article published 10.1186/s12885-015-1429-0

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us